Showing results (151-160 of 211) with videos related to
Sort By:
Pageof 22
Journal of the National Cancer Center|April 20, 2026
Long-term outcomes and clinical features of stage III non-small-cell lung cancer harboring ALK rearrangements: a multicenter retrospective study of 176 patientsFengwei Tan, Ying Jiang, Jianchun Duan, et al.Journal of the National Cancer Center|April 20, 2026
Upper gastrointestinal cancers global burden profile, trends, contributors, and attributable change in life expectancy from 1990 to 2021Yi Teng, Haoyu Zhang, Siyi He, et al.Journal of the National Cancer Center|June 12, 2026
Intrinsic and extrinsic regulators of cancer dormancy and awakeningJingwei Zhang, Md Imtiaz Khalil, Ranjan Mishra, et al.Journal of the National Cancer Center|June 12, 2026
Efficacy and safety comparisons of PD-1 versus PD-L1 inhibitors in patients with solid cancer: a systematic review and meta-analysisJun Yu, Qiaoxia Zhou, Guoqiang Wang, et al.Journal of the National Cancer Center|June 12, 2026
Study of the blood-brain barrier-penetrating KRAS G12C inhibitor JMKX1899 in KRAS G12C-mutated NSCLC with brain metastasesDanming He, Yixiang Zhu, Jia Zhong, et al.Journal of the National Cancer Center|June 12, 2026
Construction and external validation of radiomics models to detect primary prostate cancer with machine learning: a multicenter study based on 68Ga-PSMA PET/CTJiaxian Chen, Xin Jiang, Guangjie Yang, et al.Journal of the National Cancer Center|August 22, 2026
Technical review of artificial intelligence in TCR-T therapyInbum Lee, Minsoo Joo, Jong-Moon ChungJournal of the National Cancer Center|August 22, 2026
Εndogenous metabolomic responses in circadian disrupted night shift working populations: a scoping reviewBehzad Heibati, Paige Lacy, Konstantinos C MakrisJournal of the National Cancer Center|August 22, 2026
Sorafenib plus hepatic arterial infusion chemotherapy versus sorafenib plus transarterial chemoembolization in advanced hepatocellular carcinoma: a phase III trial and biomarker analysesZhicheng Lai, Zefeng Du, Lichang Huang, et al.Journal of the National Cancer Center|July 22, 2025
Five-year conditional relative survival up to 10 years post-diagnosis among adolescent and young adult breast cancer patients by age, stage, and receptor subtypeNoëlle J M C Vrancken Peeters, Daniël J van der Meer, Marleen Kok, et al.Pageof 22